Enhancing the bioavailability of resveratrol by combining it with piperine
Authors:
Top Cited Papers
- 29 June 2011
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 55 (8) , 1169-1176
Abstract
Scope:Resveratrol (3,5,4′‐trihydroxystilbene) is a phytoalexin shown to possess a multitude of health‐promoting properties in pre‐clinical studies. However, the poor in vivo bioavailability of resveratrol due to its rapid metabolism is being considered as a major obstacle in translating its effects in humans. In this study, we examined the hypothesis that piperine will enhance the pharmacokinetic parameters of resveratrol via inhibiting its glucuronidation, thereby slowing its elimination.Methods and results:Employing a standardized LC/MS assay, we determined the effect of piperine co‐administration with resveratrol on serum levels resveratrol and resveratrol‐3‐O‐β‐D‐glucuronide in C57BL mice. Mice were administered resveratrol (100 mg/kg;oral gavage) or resveratrol (100 mg/kg;oral gavage)+piperine (10 mg/kg;oral gavage), and the serum levels of resveratrol and resveratrol‐3‐O‐β‐D‐glucuronide were analyzed at different times. We found that the degree of exposure (i.e. AUC) to resveratrol was enhanced to 229% and the maximum serum concentration (Cmax) was increased to 1544% with the addition of piperine.Conclusion:Our study demonstrated that piperine significantly improves the in vivo bioavailability of resveratrol. However, further detailed research is needed to study the mechanism of improved bioavailability of resveratrol via its combination with piperine as well as its effect on resveratrol metabolism.Keywords
Funding Information
- National Institutes of Health (1R21 CA149560, R01CA114060, 1R01AR059130)
This publication has 31 references indexed in Scilit:
- Resveratrol in cancer management: where are we and where we go from here?Annals of the New York Academy of Sciences, 2011
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor AxisCancer Research, 2010
- Disruption of Androgen and Estrogen Receptor Activity in Prostate Cancer by a Novel Dietary Diterpene Carnosol: Implications for ChemopreventionCancer Prevention Research, 2010
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer StudyCancer Prevention Research, 2010
- Green tea polyphenols for prostate cancer chemoprevention: A translational perspectivePhytomedicine, 2010
- Resveratrol Imparts Photoprotection of Normal Cells and Enhances the Efficacy of Radiation Therapy in Cancer CellsPhotochemistry and Photobiology, 2008
- Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive AgentCancer Epidemiology, Biomarkers & Prevention, 2007
- Oncogenicity evaluation of resveratrol in p53(±) (p53 knockout) miceFood and Chemical Toxicology, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?The FASEB Journal, 2005